(Q33897217)

29 July 2017

1 reference

title

A review of the epidemiology and approaches to the treatment of social anxiety disorder (English)

1 reference

29 July 2017

1 reference

social anxiety disorder

1 reference

Sareen L

1

1 reference

PubMed ID

10776832

29 July 2017

Stein M

series ordinal

2

1 reference

29 July 2017

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

59

1 reference

29 July 2017

497-509

1 reference

29 July 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200059030-00007

29 July 2017

0 references

cites work

The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents.

1 reference

12 December 2020

Setting diagnostic thresholds for social phobia: considerations from a community survey of social anxiety

1 reference

12 December 2020

Tranylcypromine in social phobia.

1 reference

12 December 2020

Fluoxetine efficacy in social phobia.

1 reference

12 December 2020

Placebo-controlled trial of moclobemide in social phobia

1 reference

12 December 2020

Psychopharmacological treatment of social phobia; a double blind placebo controlled study with fluvoxamine

1 reference

12 December 2020

Fluvoxamine treatment of social phobia (social anxiety disorder): a double-blind, placebo-controlled study

1 reference

12 December 2020

Social phobia. Comorbidity and morbidity in an epidemiologic sample

1 reference

12 December 2020

Dimensional Versus Categorical Response to Moclobemide in Social Phobia

1 reference

12 December 2020

Buspirone in social phobia.

1 reference

12 December 2020

Prevalence of mental disorders and psychosocial impairments in adolescents and young adults

1 reference

12 December 2020

One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age.

1 reference

12 December 2020

Citalopram in the treatment of social phobia: a report of three cases

1 reference

12 December 2020

Social phobia in general health care: an unrecognised undertreated disabling disorder

1 reference

12 December 2020

Brofaromine for social phobia: a multicenter, placebo-controlled, double-blind study

1 reference

12 December 2020

Social phobia subtypes in the National Comorbidity Survey.

1 reference

12 December 2020

Effect of oxprenolol on stage-fright in musicians

1 reference

12 December 2020

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study

1 reference

12 December 2020

Sertraline for social phobia: a double-blind, placebo-controlled crossover study

1 reference

12 December 2020

The treatment of social phobia: a critical assessment

1 reference

12 December 2020

Psychotherapy in the overall management strategy for social anxiety disorder.

1 reference

12 December 2020

Use of medical services and treatment for panic disorder with agoraphobia and for social phobia

1 reference

12 December 2020

The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study.

1 reference

12 December 2020

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

12 December 2020

Social phobia: long-term treatment outcome and prediction of response--a moclobemide study

1 reference

12 December 2020

Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial

1 reference

12 December 2020

Quality of life in social phobia.

1 reference

12 December 2020

Social phobia: epidemiology, recognition, and treatment

1 reference

12 December 2020

Pharmacotherapy of social anxiety disorder

1 reference

12 December 2020

Social phobia: a comparative clinical study

1 reference

12 December 2020

Treatment of social phobia with clonazepam and placebo.

1 reference

12 December 2020

Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.

1 reference

12 December 2020

Pharmacotherapy of social phobia. A controlled study with moclobemide and phenelzine

1 reference

12 December 2020

Meta-analysis of cognitive-behavioral treatments for social phobia

1 reference

12 December 2020

Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia

1 reference

12 December 2020

Social phobia. Longitudinal course and long-term outcome of cognitive-behavioral treatment.

1 reference

12 December 2020

Social phobia. Review of a neglected anxiety disorder

1 reference

12 December 2020

New uses for antidepressants: social phobia.

1 reference

12 December 2020

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

12 December 2020

Treatment of social phobia with bupropion.

1 reference

12 December 2020

Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey

1 reference

12 December 2020

Moclobemide in social phobia

1 reference

12 December 2020

A double-blind placebo-controlled trial of paroxetine in the management of social phobia (social anxiety disorder) in South Africa.

1 reference

12 December 2020

Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome

1 reference

12 December 2020

The International Multicenter Clinical Trial Group on Moclobemide in Social Phobia. Moclobemide in social phobia. A double-blind, placebo-controlled clinical study

1 reference

12 December 2020

Co-morbidity and familial aggregation of alcoholism and anxiety disorders

1 reference

12 December 2020

Moclobemide in social phobia: a controlled dose-response trial

1 reference

12 December 2020

The nature of social anxiety disorder

1 reference

12 December 2020

Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety.

1 reference

12 December 2020

Public-speaking fears in a community sample. Prevalence, impact on functioning, and diagnostic classification

1 reference

12 December 2020

Phenelzine vs atenolol in social phobia. A placebo-controlled comparison

1 reference

12 December 2020

Generalized social phobia. Reliability and validity

1 reference

12 December 2020

Comorbidity in social anxiety disorder: impact on disease burden and management

1 reference

12 December 2020

Paroxetine in the treatment of generalized social phobia: open-label treatment and double-blind placebo-controlled discontinuation.

1 reference

12 December 2020

1 reference

12 December 2020

SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.

1 reference

12 December 2020

Social phobia: a comparison of behavior therapy and atenolol

1 reference

12 December 2020

Social phobia: an update

1 reference

12 December 2020

Imipramine in the treatment of social phobia.

1 reference

12 December 2020

10.2165/00003495-200059030-00007

Identifiers

DOI

1 reference

PubMed ID

10776832

Dimensions Publication ID

29 July 2017

0 references

1 reference

PubMed ID

10776832